Search filters

Filters
Clear All

Phase

  • 5
  • 5
  • 3
  • 2
  • 6
  • 21
  • 5
  • 21

Found 21 Hodgkin's Disease trials

A listing of Hodgkin's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
All genders
Observational
This study investigates the use of unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other conditions. The purpose of this study is to understand how well patients recover neutrophil levels, a type of white blood cell important for fighting infections, after …
18 years or above
All genders
Phase 1
Interventional
This study investigates hematologic malignancies. The purpose of this study is to assess the safety and feasibility of using autologous anti-CD45 CAR T cells in combination with CD45 base edited hematopoietic stem and progenitor cells.The study evaluates the effectiveness and safety of these treatments in patients who have relapsed or …
12 years or above
All genders
Phase 1/2
Interventional
This study investigates the safety, tolerability, and effects of an investigational medication in individuals with blood cancers that have not responded to previous treatments. The purpose of this study is to determine how well the investigational medication works when used alone or in combination with other anticancer agents. Participants will …
99 years or below
All genders
To investigate immunologic changes in Hodgkin Lymphoma patients treated with itacitinib (a JAK inhibitor) in combination with everolimus (an mTOR inhibitor).
18 years or above
All genders
Phase 1
Interventional
This study investigates an investigational therapy for treating HIV-associated aggressive B-cell non-Hodgkin lymphoma that has either returned or not responded to previous treatments. The purpose is to evaluate the safety and feasibility of using genetically modified T cells, known as CAR-T therapy, which are designed to target a specific protein …
99 years or below
All genders
To determine potential mechanisms of CD20 loss after CD20-directed therapy in non-Hodgkin lymphomas.
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and appropriate dosing of investigational cells in patients with T Cell Non-Hodgkin Lymphoma. The purpose of this study is to determine how well these cells can be tolerated by patients and to identify the best dose for future studies. The focus is on patients whose …
18 years or above
All genders
Phase 4
Interventional
This study investigates the long-term safety and effects of an investigational medication in people with Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), or Non-Hodgkin Lymphoma (NHL) who have already received treatment. The purpose of this study is to provide participants from a previous study with the opportunity to continue …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates the safety and effectiveness of an investigational medication in patients with advanced blood cancers, including Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia, and high-risk Myelodysplastic Syndrome.Participants in the study will receive the investigational medication either alone or in combination with other treatments. The study will monitor the …
UPCC 12420 A Phase 2, Open- Label, Single-Arm, Multicohort, Multicenter Trial to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects with Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma (NHL)
18 years or above
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with relapsed or refractory indolent B-cell Non-Hodgkin Lymphoma (NHL), specifically follicular lymphoma (FL) and marginal zone lymphoma (MZL). The purpose of this study is to understand how well the investigational medication works in treating these types of …
1 - 10 of 21